Sign In

Mark Kotter

Clinician, scientist & entrepreneur transitioning biology to engineering for the benefit of patients.

Mark Kotter is a distinguished neurosurgeon, stem cell biologist, and successful entrepreneur dedicated to enhancing patient outcomes.

His groundbreaking work combines synthetic and stem cell biology, resulting in the development of revolutionary technology that streamlines the production of human cells for various applications like research, drug development, and cell therapies.

Mark is the visionary founder of the acclaimed synthetic cell company bit bio and a co-founder of the innovative cultured meat startup Meatable.

His impressive educational background includes a Doctor of Philosophy (PhD) and a Master of Philosophy (MPhil) from the prestigious University of Cambridge, as well as a Doctor of Medicine (MD) with Distinction from Karl-Franzens-Universität Graz / University of Graz.

Throughout his career, Mark has held key positions in renowned organizations such as NIHR Clinician Scientist at University of Cambridge, Professeur Invité at Université Paris Descartes, Co-Founder at Meatable, and various roles in pioneering initiatives like the Spinal Cord Injury Forum at AOSpine and the NIHR Brain Injury MedTech Co-operative.

His extensive experience also includes leadership roles as Founder of bit bio, Founder of Myelopathy.org, Clinical Lecturer in Neurosurgery at University of Cambridge, and Research Group Leader at the Max Planck Institute for Experimental Medicine.

Mark's expertise and relentless dedication to advancing medical and biological sciences make him a prominent figure in the fields of neurosurgery, stem cell biology, and entrepreneurship.

Mark Kotter
Add to my network

Location

Cambridge, United Kingdom